Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Inflammatory bowel disease (IBD) may also involve various extra-intestinal organs. Clinical studies have found asymptomatic/symptomatic pulmonary involvement in 1% to 6% of patients with IBD. The present study histopathologically investigated pulmonary involvement in an experimental model of colitis in order to demonstrate pulmonary tissue involvement in IBD and to expose potential etiological factors. It also explored the relation between inflammation and tissue concentrations of vascular endothelial growth factor (VEGF) and tumor necrosis factor α (TNF-α). Methods: The study comprised 24 male Wistar albino rats. The rats were divided into four groups of six rats each. Acute colitis was induced in two separate groups using either the dextran sulphate sodium (DSS) or trinitrobenzene sulfonic acid (TNBS) method, while the other two groups were used as controls for each model of colitis. Wallace scoring was used for macroscopic assessment of colitis, and the lungs were histopathologically examined. Concentrations of VEGF and TNF-α in pulmonary tissue were measured by the enzyme-linked immunosorbent assay method. Results: The number of animals that had alveolar hemorrhage was significantly higher in the TNBS-induced colitis and DSS-induced colitis groups compared to their own control groups (p = 0.015 and p = 0.015, respectively). VEGF and TNF-α concentrations in pulmonary tissues were significantly increased in both the TNBS colitis and DSS colitis groups compared to their own control groups (p = 0.002 and p = 0.004, respectively; and p = 0.002 and p = 0.002, respectively). Conclusions: The present study demonstrated that significant and serious histopathological changes directly associated with colitis occur in the lungs in IBD.
Abstract
Background/Aims: Inflammatory bowel disease (IBD) may also involve various extra-intestinal organs. Clinical studies have found asymptomatic/symptomatic pulmonary involvement in 1% to 6% of patients with IBD. The present study histopathologically investigated pulmonary involvement in an experimental model of colitis in order to demonstrate pulmonary tissue involvement in IBD and to expose potential etiological factors. It also explored the relation between inflammation and tissue concentrations of vascular endothelial growth factor (VEGF) and tumor necrosis factor α (TNF-α). Methods: The study comprised 24 male Wistar albino rats. The rats were divided into four groups of six rats each. Acute colitis was induced in two separate groups using either the dextran sulphate sodium (DSS) or trinitrobenzene sulfonic acid (TNBS) method, while the other two groups were used as controls for each model of colitis. Wallace scoring was used for macroscopic assessment of colitis, and the lungs were histopathologically examined. Concentrations of VEGF and TNF-α in pulmonary tissue were measured by the enzyme-linked immunosorbent assay method. Results: The number of animals that had alveolar hemorrhage was significantly higher in the TNBS-induced colitis and DSS-induced colitis groups compared to their own control groups (p = 0.015 and p = 0.015, respectively). VEGF and TNF-α concentrations in pulmonary tissues were significantly increased in both the TNBS colitis and DSS colitis groups compared to their own control groups (p = 0.002 and p = 0.004, respectively; and p = 0.002 and p = 0.002, respectively). Conclusions: The present study demonstrated that significant and serious histopathological changes directly associated with colitis occur in the lungs in IBD.
참고문헌 (26)
- Su CG, "Extraintestinal manifestations of inflammatory bowel disease", Gastroenterol Clin North Am, 31, pp.307~327 (2002)
- Kraft SC, "Unexplained bronchopulmonary disease with inflammatory bowel disease", Arch Intern Med, 136, pp.454~459 (1976)
- Camus P, "The lung in inflammatory bowel disease", Medicine, 72, pp.151~183 (1993)
- Higenbottam T, "Bronchial disease in ulcerative colitis", Thorax, 35, pp.581~585 (1980)
- Garg K, "Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features", J Thorac Imaging, 8, pp.159~163 (1993)
- Podolsky DK, "Inflammatory bowel disease", N Engl J Med, 347, pp.417~429 (2002)
- Sandborn WJ, "Biologic therapy of inflammatory bowel disease", Gastroenterology, 122, pp.1592~1608 (2002)
- Koutroubakis IE, "Role of angiogenesis in inflammatory bowel disease", Inflamm Bowel Dis, 12, pp.515~523 (2006)
- Le Cras TD, "VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice", Am J Physiol Lung Cell Mol Physiol, 287, pp.L134~L142 (2004)
- Songur N, "Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease", J Clin Gastroenterol, 37, pp.292~298 (2003)
- Mahadeva R, "Clinical and radiological characteristics of lung disease in inflammatory bowel disease", Eur Respir J, 15, pp.41~48 (2000)
- Marvisi M, "Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis", Eur Respir J, 16, pp.965~968 (2000)
- Fireman Z, "The use of induced sputum in the assessment of pulmonary involvement in Crohn’s disease", Am J Gastroenterol, 95, pp.730~734 (2000)
- Kawada M, "Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease", World J Gastroenterol, 13, pp.5581~5593 (2007)
- Morris GP, "Hapten-induced model of chronic inflammation and ulceration in the rat colon", Gastroenterology, 96, pp.795~803 (1989)
- Cooper HS, "Clinicopathologic study of dextran sulfate sodium experimental murine colitis", Lab Invest, 69, pp.238~249 (1993)
- Wallace JL, "An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis", Am J Physiol, 258(4 Pt 1), pp.G527~G534 (1990)
- Obermeier F, "Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice", Clin Exp Immunol, 116, pp.238~245 (1999)
- Lowry OH, "Protein measurement with the Folin phenol reagent", J Biol Chem, 193, pp.265~275 (1951)
- Storch I, "Pulmonary manifestations of inflammatory bowel disease", Inflamm Bowel Dis, 9, pp.104~115 (2003)
- Bewig B, "Crohn’s disease mimicking sarcoidosis in bronchoalveolar lavage", Respiration, 66, pp.467~469 (1993)
- te Velde AA, "Critical appraisal of the current practice in murine TNBS-induced colitis", Inflamm Bowel Dis, 12, pp.995~999 (2006)
- Komai H, "Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery", Perfusion, 20, pp.77~82 (2005)
- Hocking D, "Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema", J Appl Physiol, 72, pp.179~185 (1992)
- Gursoy S, "Subclinical alveolar involvement in ulcerative colitis", Inflamm Bowel Dis, 11, pp.372~375 (2005)
- Sandborn WJ, "Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety", Inflamm Bowel Dis, 5, pp.119~133 (1999)